The Future of Respiratory Virus Mitigation in Buildings

The Future of Respiratory Virus Mitigation in Buildings.

As the world continues to grapple with the COVID-19 pandemic and other respiratory viruses, the importance of mitigating indoor transmission of these diseases in buildings has become a critical concern. To address this issue, GPS Air’s Vice President of Products and Marketing, Kevin Boyle, and Founder and CTO, Charles Waddell, shared their insights and expertise on the latest episode of Conversation to the Edge by Service Logic.

During the episode, the experts emphasized the importance of a multi-faceted approach to respiratory virus mitigation in buildings. Strategies include increasing ventilation and filtration, implementing social distancing protocols, increasing cleaning and disinfection, and encouraging the wearing of face masks or other personal protective equipment (PPE). These methods aim to reduce the concentration of respiratory viruses in the air and on surfaces, making it less likely for people to contract the virus.

Waddell stressed the significance of a multi-layered solution approach, combining multiple technologies to achieve better results. The approach involves engineering and administrative controls, PPE, social distancing and hygiene practices, and monitoring and tracking.

Boyle also highlighted the critical role of indoor air quality (IAQ) in respiratory virus mitigation. Poor IAQ can increase the risk of respiratory infections and aggravate existing respiratory conditions. Buildings that are poorly ventilated or have high levels of indoor air pollution can create an environment conducive to spreading respiratory viruses such as COVID-19.

Building owners and managers are urged to work with public health officials and experts to develop and implement effective respiratory virus mitigation strategies. By employing the right techniques and strategies, the risk of indoor transmission of respiratory viruses can be reduced, making buildings safer for everyone.

About GPS Air

GPS Air is a leading provider of innovative air purification solutions for commercial and residential properties. The company’s technology combines mechanical filtration, UV-C light, and photocatalytic oxidation to remove airborne pollutants, viruses, and bacteria. With a commitment to sustainability and efficiency, GPS Air helps create healthy indoor environments while reducing energy consumption and operating costs.
For more information, please visit https://gpsair.com/.

Follow us on social media for the latest updates in B2B!

Image

Latest

ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More
vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More